NCT02305680已完成不适用
EPICOR Asia-China Extension. Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China Extension
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 2,334
- 试验地点
- 1
- 主要终点
- Long-term antithrombotic management patterns in a real-life setting by assessing the medication and treatment prescribed by physicians
研究概览
简要总结
This study is to describe the long-term antithrombotic management patterns in a real-life setting for patients hospitalized with an acute coronary syndrome in China.
详细描述
This study is to describe the long-term (3 to 5 years after the acute coronary syndrome index event) antithrombotic management patterns in a real-life setting for patients hospitalized with an acute coronary syndrome (i.e. ST-segment Elevation Myocardial Infarction, Non-ST-segment Elevation Myocardial Infarction, Unstable Angina) in China.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Written informed consent has been provided.
- •Contact Order Form has been provided
- •Aged 18 years or older.
- •Enrolled in EPICOR Asia study and completed the 2 year follow-up.
排除标准
- •Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient (e.g. tourist, non-native speaker or does not understand the local language, psychiatric disturbances, alcohol or drug abuse).
- •Already included in the EPICOR Asia-China Extension observational study.
- •Presence of serious/severe co-morbidities in the opinion of the investigator which may limit short term (i.e. 6 month) life expectancy.
- •Current participation in an interventional clinical trial.
- •Patients receiving ticagrelor beyond 12 months and other off label use.
结局指标
主要结局
Long-term antithrombotic management patterns in a real-life setting by assessing the medication and treatment prescribed by physicians
时间窗: From 2 years after the acute coronary syndrome index event, assessed up to 5 years
次要结局
- Clinical outcomes by record the number and type of cardiovascular and non-cardiovascular events(From 2 years after the acute coronary syndrome index event, assessed up to 5 years)
- Quality of life by assessing EQ-5D questionnaire.(2 years,2.5years,3years,3.5years,4years,4.5years,5years after the acute coronary syndrome index event)
- Health care resource consumption and related costs by assessing the detail hospitalization and outpatient cost.(From 2 years after the acute coronary syndrome index event, assessed up to 5 years)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After DischargeACSMyocardial InfarctionAcute Coronary SyndromeCoronary Artery DiseaseUnstable AnginaNCT01171404AstraZeneca10,568
已完成
不适用
Long-term Follow-up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients in RussiaAcute Coronary SyndromeNCT01373957AstraZeneca600
已完成
不适用
Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in AsiaAcute Coronary SyndromeNCT01361386AstraZeneca13,011
Unknown
不适用
Management of Patients on Long Term Anticoagulation Therapy Undergoing a Primary Total Hip of Knee ReplacementPostoperative ComplicationsNCT02714673Association pour le Développement et l'Enseignement de la Chirurgie Réparatrice et Orthopédique600
已完成
不适用
Description of Patients With Acute Venous Thromboembolism in the UK's Clinical Practice Research Datalink Linked With Hospital Episode Statistics Dataset (CPRD-HES)Venous ThromboembolismNCT02661568Bristol-Myers Squibb38,409